Company / EPS (Basic)
Enveric Biosciences, Inc. EPS (Basic) History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$20.47
FY2019
5-year range
-$20.47 / -$0.21
FY2017-FY2019
Trend
-2629.3%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) changed -2629% YoY in FY2019, a notable deviation from the 2-year average annual change of -1443%.
Based on SEC 10-K filings.
-20.47 in FY2019.
Declined from $-0.21 to $-20.47 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, eps (basic) decreased 2629.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$20.47 | -2629.3% |
| FY2018 | -$0.75 | -257.1% |
| FY2017 | -$0.21 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026